journal article·2018-04

Zinc Oxide Nanoparticles and Voltage‐Gated Human Kv11.1 Potassium Channels Interact through a Novel Mechanism

Stefania Piscopo, Euan R. Brown

Small· Volume 14· Issue 15
Publisher page

Abstract

Abstract Membrane–nanoparticle interactions are important in determining the effects of manufactured nanomaterials on cell physiology and pathology. Here, silica, titanium, zinc, and magnesium oxide nanoparticles are screened against human hERG (Kv11.1) voltage‐gated potassium channels under a whole‐cell voltage clamp. 10 µg mL−1 ZnO uniquely increases the amplitude of the steady‐state current, decreases the rate of hERG current inactivation during steady‐state depolarization, accelerates channel deactivation during resurgent tail currents, and shows no significant alteration of current activation rate or voltage dependence. In contrast, ZnCl2 causes increased current suppression with increasing concentration and fails to replicate the nanoparticle effect on decreasing inactivation. The results show a novel class of nanoparticle–biomembrane interaction involving channel gating rather than channel block, and have implications for the use of nanoparticles in biomedicine, drug delivery applications, and nanotoxicology.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neuroscience and Neural Engineering · Cardiac electrophysiology and arrhythmias · Ion channel regulation and function

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Stazione Zoologica Anton Dohrn Villa Comunale 80121 Naples Italy

Institute of Biological Chemistry Biophysics and Bioengineering William Perkin Building School of Engineering and Physical Sciences Heriot Watt University Edinburgh EH14 4AS UK

Funding

Seventh Framework Programme

References (50)

Show source-provided references
1. 10.1038/nmat244210.1038/nmat2442 ↗
2. 10.1016/j.tiv.2015.04.02110.1016/j.tiv.2015.04.021 ↗
3. 10.1016/j.chemphyslip.2004.09.00110.1016/j.chemphyslip.2004.09.001 ↗
4. 10.1021/jp903393610.1021/jp9033936 ↗
5. 10.1073/pnas.080729610510.1073/pnas.0807296105 ↗
6. 10.1021/nl080080l10.1021/nl080080l ↗
7. 10.1073/pnas.122014311010.1073/pnas.1220143110 ↗
8. 10.1016/j.neuro.2008.12.00510.1016/j.neuro.2008.12.005 ↗
9. 10.1016/j.tox.2009.08.00510.1016/j.tox.2009.08.005 ↗
10. 10.1021/nl047996m10.1021/nl047996m ↗
11. 10.1038/nnano.2011.5810.1038/nnano.2011.58 ↗
12. 10.1038/nrd255210.1038/nrd2552 ↗
13. 10.1016/0092-8674(95)90340-210.1016/0092-8674(95)90340-2 ↗
14. 10.1016/j.cell.2017.03.04810.1016/j.cell.2017.03.048 ↗
15. 10.1152/physrev.00036.201110.1152/physrev.00036.2011 ↗
16. 10.1021/ja910675v10.1021/ja910675v ↗
17. 10.1021/nl060860z10.1021/nl060860z ↗
18. 10.1021/nn303630410.1021/nn3036304 ↗
19. 10.1016/S0006-3495(99)76889-X10.1016/S0006-3495(99)76889-X ↗
20. 10.1088/0957-4484/20/45/45510110.1088/0957-4484/20/45/455101 ↗
21. 10.1016/j.toxlet.2009.01.00810.1016/j.toxlet.2009.01.008 ↗
22. 10.1016/j.chemosphere.2010.12.06910.1016/j.chemosphere.2010.12.069 ↗
23. 10.1016/j.toxrep.2015.03.01510.1016/j.toxrep.2015.03.015 ↗
24. 10.1080/1093452060096617710.1080/10934520600966177 ↗
25. Sakmann B. · 2009
26. 10.1021/la203568n10.1021/la203568n ↗
27. 10.1016/j.jcis.2013.05.01010.1016/j.jcis.2013.05.010 ↗
28. 10.1159/00010752710.1159/000107527 ↗
29. 10.1152/ajpcell.00462.200910.1152/ajpcell.00462.2009 ↗
30. Piper D. R. · Novartis Found. Symp. · 2005 · 266 · 4610.1002/047002142X.ch5 ↗
31. 10.1126/science.212251910.1126/science.2122519 ↗
32. 10.1073/pnas.88.12.509210.1073/pnas.88.12.5092 ↗
33. 10.1038/379833a010.1038/379833a0 ↗
34. 10.1113/JP27009510.1113/JP270095 ↗
35. Herzberg I. M. · J. Physiol. · 1998 · 3 · 511
36. 10.1038/nature0471010.1038/nature04710 ↗
37. 10.1152/ajpcell.00462.200910.1152/ajpcell.00462.2009 ↗
38. 10.1016/0038-1098(79)90754-310.1016/0038-1098(79)90754-3 ↗
39. 10.1021/tx400424310.1021/tx4004243 ↗
40. 10.1021/jp301671b10.1021/jp301671b ↗
41. 10.1016/S0946-672X(97)80032-610.1016/S0946-672X(97)80032-6 ↗
42. 10.1042/BST036131710.1042/BST0361317 ↗
43. 10.1016/0079-6816(93)90013-L10.1016/0079-6816(93)90013-L ↗
44. 10.1111/j.1151-2916.2003.tb03600.x10.1111/j.1151-2916.2003.tb03600.x ↗
45. 10.1016/0014-5793(77)80629-710.1016/0014-5793(77)80629-7 ↗
46. 10.1113/jphysiol.2006.10833210.1113/jphysiol.2006.108332 ↗
47. 10.2174/156652401366613111113005810.2174/1566524013666131111130058 ↗
48. 10.1021/ja107583h10.1021/ja107583h ↗
49. 10.2174/13816120677758510210.2174/138161206777585102 ↗
50. 10.2203/dose-response.10-002.Siddique10.2203/dose-response.10-002.Siddique ↗